𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Detection of heterozygous deletions and duplications in the MECP2 gene in Rett syndrome by Robust Dosage PCR (RD-PCR)

✍ Scribed by Jinxiu Shi; Akane Shibayama; Qiang Liu; Vu Q. Nguyen; Jinong Feng; Mónica Santos; Teresa Temudo; Patricia Maciel; Steve S. Sommer


Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
272 KB
Volume
25
Category
Article
ISSN
1059-7794

No coin nor oath required. For personal study only.

✦ Synopsis


Fifty to eighty percent of Rett syndrome (RTT) cases have point mutations in the gene encoding methyl-CpG-binding protein-2 (MECP2). A fraction of MECP2 negative classical RTT patients has large heterozygous deletions. Robust Dosage PCR (RD-PCR) assays were developed as a rapid, convenient and accurate method to detect large heterozygous deletions and duplications. A blinded analysis was performed for 65 RTT cases from Portugal by RD-PCR in the coding exons 2-4 of the MECP2 gene. Neither the patients with point mutations nor the non-classical RTT patients without point mutation had a deletion or duplication. One of remaining eight female patients with classical RTT without point mutation had a heterozygous deletion. This is the first report of a deletion spanning the entire MECP2 gene. The deletion was confirmed by southern blotting analysis and the deletion junction was localized 37kb upstream from exon 1 and 18kb downstream from exon 4. No duplications were detected. Our results suggest that RD-PCR is an accurate and convenient molecular diagnostic method.


📜 SIMILAR VOLUMES


Real-time quantitative PCR as a routine
✍ Francesca Ariani; Francesca Mari; Chiara Pescucci; Ilaria Longo; Mirella Bruttin 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 243 KB 👁 2 views

## Communicated by Garry Cutting Mutations in the X-linked methyl-CpG-binding protein 2 gene (MECP2) are found in 70-80% of cases of classical Rett syndrome (RTT) and in about 50% of cases of preserved speech variant (PSV). This high percentage of MECP2 mutations, especially in classical RTT cases

Rapid detection by fluorescent multiplex
✍ Christiane Duponchel; Christiana Di Rocco; Marco Cicardi; Mario Tosi 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 408 KB 👁 2 views

Hereditary angioedema (HAE) is due to a variety of defects in the C1 inhibitor gene (C1NH gene), including approximately 20% of partial deletions/duplications whose boundaries are usually within Alu repeats. To ensure complete molecular characterization of C1 inhibitor deficiencies a fluorescent mul

Detection of heterozygous SALL1 deletion
✍ Wiktor Borozdin; Katharina Steinmann; Beate Albrecht; Armand Bottani; Koenraad D 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 357 KB 👁 1 views

Townes-Brocks syndrome (TBS) is an autosomal dominantly inherited disorder characterized by ear, anal, limb, and renal malformations, and results from mutations in the gene SALL1. All SALL1 mutations previously found in TBS patients create preterminal termination codons. In accordance with the findi

Expanding the spectrum of TBX5 mutations
✍ Wiktor Borozdin; Ana M. Bravo Ferrer Acosta; Michael J. Bamshad; Elke M. Botzenh 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 151 KB 👁 1 views

Mutations in the gene TBX5 cause Holt-Oram syndrome (HOS), an autosomal dominant disorder characterized by anterior (i.e., radial ray) upper limb malformations and congenital heart defects and/or cardiac conduction anomalies. The detection rate for TBX5 mutations in HOS patients has been given as 30

Prenatal diagnosis of X-linked hyper-IGM
✍ R. Jayoussi–Assalia; A. Etzioni; L.D. Notarangelo; R. Brill-Zamir; L. Kasinetz; 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 55 KB 👁 2 views

We present the first report of prenatal diagnosis of X-linked hyper-IgM syndrome by PCR-mediated site directed mutagenesis (PSM) in a woman known to carry the Q220X mutation in the CD40L gene. Using the simple PSM assay, the Q220X mutation was identified by chorionic villous sampling (CVS) at 11 wee